SCHEMBL30815301

SCHEMBL30815301

COC(=O)c1ccc(Nc2nc([Sn](C)(C)C)ccc2[N+](=O)[O-])cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.51
▸ KMT2A Q03164 6/20 0.51
▸ MAPT P10636 6/20 0.50
▸ MAPK1 P28482 3/20 0.50
▸ POLB P06746 2/20 0.50
▸ NPC1 O15118 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ AURKA O14965 1/20 0.43
▸ GSK3A P49840 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ ROCK1 Q13464 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27226838 1.00 MEN1 (0.51) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL27226363 0.83 MEN1 (0.56) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL27226844 0.83 MEN1 (0.53) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL21671950 0.83 MAPT (0.58) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL27226888 0.83 MEN1 (0.53) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL27226492 0.82 HSF1 (0.55) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL27226653 0.81 MEN1 (0.51) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL27226136 0.81 MEN1 (0.51) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL27226540 0.81 MEN1 (0.51) MEN1KMT2AMAPTMAPK1POLB
SCHEMBL30815539 0.81 MAPT (0.41) MEN1KMT2AMAPTMAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594318-A1 AKT1 MODULATORS Alterome Therapeutics, Inc. (US) 2025-08-06 — — EP disclosed
WO-2024073371-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback